Search Results - "Cavazzoni, P"

Refine Results
  1. 1

    Mapping susceptibility genes for bipolar disorder : a pharmacogenetic approach based on excellent response to lithium by TURECKI, G, GROF, P, ROBERTSON, C, BREWER, C, HUDSON, T. J, ROULEAU, G. A, ALDA, M, GROF, E, D'SOUZA, V, LEBUIS, L, MARINEAU, C, CAVAZZONI, P, DUFFY, A, BETARD, C, ZVOLSKY, P

    Published in Molecular psychiatry (01-09-2001)
    “…Genetic mapping studies in bipolar disorder (BD) have been hampered by the unclear boundaries of the phenotypic spectrum, and possibly, by the complexity of…”
    Get full text
    Journal Article
  2. 2

    Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder by TURECKI, G, GROF, P, VOJTECHOVSKY, M, ZVOLSKY, P, JOOBER, R, NILSSON, A, PROCHAZKA, H, LICHT, R, RASMUSSEN, N, SCHOU, M, VESTERGAARD, P, HOLZINGER, A, CAVAZZONI, P, SCHUMANN, C, THAU, K, ROULEAU, G, ALDA, M, DUFFY, A, GROF, E, AHRENS, B, BERGHÖFER, A, MÜLLER-OERLINGHAUSEN, B, DVORAKOVA, M, LIBIGEROVA, E

    Published in Molecular psychiatry (01-11-1998)
    “…Several studies have indicated that patients with bipolar disorder (BD) who respond well to lithium prophylaxis constitute a biologically distinct subgroup…”
    Get full text
    Journal Article
  3. 3

    Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists by LLedó, A., Dellva, M. A., Strombom, I. M., Wilkie, J. L., Jungemann, Mark E., Royer, M. G., Simmons, V. E., Cavazzoni, P. A.

    Published in European journal of neurology (01-06-2007)
    “…In response to concern about the reported frequency of ergot‐associated valvulopathy in patients with Parkinson's disease (PD), Eli Lilly and Company updated…”
    Get full text
    Journal Article
  4. 4

    Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study by Turecki, G., Grof, P., Cavazzoni, P., Duffy, A., Grof, E., Martin, R., Joober, R., Rouleau, G.A., Alda, M.

    Published in American journal of medical genetics (20-08-1999)
    “…Over the last three years several studies have investigated the hypothesis of linkage between bipolar disorder and markers on chromosome 18. Although…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Anticipation in bipolar affective disorder: Is age at onset a valid criterion? by Alda, M., Grof, P., Ravindran, L., Cavazzoni, P., Duffy, A., Grof, E., Zvolský, P., Wilson, J.

    Published in American journal of medical genetics (04-12-2000)
    “…Anticipation has been suggested among the genetic mechanisms of bipolar disorder (BD), prompting the search for unstable DNA sequences. Past studies of…”
    Get full text
    Journal Article
  7. 7

    No association between chromosome-18 markers and lithium-responsive affective disorders by TURECKI, G, ALDA, M, GROF, P, GROF, E, MARTIN, R, CAVAZZONI, P. A, DUFFY, A, MACIEL, P, ROULEAU, G. A

    Published in Psychiatry research (26-06-1996)
    “…An allelic association study of excellent responders to lithium was conducted with a candidate gene (Golf, a G-protein receptor gene) and five other…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Is response to prophylactic lithium a familial trait? by GROF, Paul, DUFFY, Anne, CAVAZZONI, Patrizia, GROF, Eva, GARNHAM, Julie, MACDOUGALL, Marsha, O'DONOVAN, Claire, ALDA, Martin

    Published in The journal of clinical psychiatry (01-10-2002)
    “…Selecting a drug according to the treatment response in a relative has been widely accepted advice in the management of mood disorders. However, this…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States by Buse, John B, Cavazzoni, Patrizia, Hornbuckle, Kenneth, Hutchins, David, Breier, Alan, Jovanovic, Lois

    Published in Journal of clinical epidemiology (01-02-2003)
    “…Treatment-emergent diabetes mellitus (DM) has been described for conventional and atypical antipsychotics. In our study, antipsychotic prescription claims from…”
    Get full text
    Journal Article
  14. 14

    Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia by Breier, Alan, Berg, Paul H., Thakore, Jogin H., Naber, Dieter, Gattaz, Wagner F., Cavazzoni, Patrizia, Walker, Daniel J., Roychowdhury, Suraja M., Kane, John M.

    Published in The American journal of psychiatry (01-10-2005)
    “…OBJECTIVE: The efficacy and safety of olanzapine were compared with those of ziprasidone. METHOD: This was a multicenter randomized, double-blind,…”
    Get full text
    Journal Article
  15. 15

    A prospective study of the Offspring of bipolar parents responsive and nonresponsive to lithium treatment by DUFFY, Anne, ALDA, Martin, KUTCHER, Stan, CAVAZZONI, Patrizia, ROBERTSON, Carrie, GROF, Eva, GROF, Paul

    Published in The journal of clinical psychiatry (01-12-2002)
    “…The descriptions of clinical course among bipolar youths vary significantly and differ markedly from the findings described in classical studies of bipolar…”
    Get full text
    Journal Article
  16. 16

    Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo by SOWELL, Margaret O, MUKHOPADHYAY, Nitai, CAVAZZONI, Patrizia, SHANKAR, Sudha, STEINBERG, Helmut O, BREIER, Alan, BEASLEY, Charles M, DANANBERG, Jamie

    “…The goal of this study was to evaluate the effect of olanzapine or risperidone treatment on beta-cell function in healthy volunteers. Subjects were randomly…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial by Cavazzoni, Patrizia, Tanaka, Yoko, Roychowdhury, Suraja M., Breier, Alan, Allison, David B.

    Published in European neuropsychopharmacology (01-03-2003)
    “…Weight gain is associated with treatment with olanzapine and other psychotropic agents. Nizatidine, a histamine H-2 receptor antagonist, has been proposed to…”
    Get full text
    Journal Article
  19. 19

    A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia by KRYZHANOVSKAYA, Ludmila A, JESTE, Dilip V, YOUNG, Carrie A, POLZER, John P, RODDY, Tamra E, JANSEN, Joe F, CARLSON, Janice L, CAVAZZONI, Patrizia A

    Published in The journal of clinical psychiatry (01-06-2006)
    “…Olanzapine and other antipsychotics are not approved by the U.S. Food and Drug Administration to treat behavioral disturbances associated with dementia, but…”
    Get full text
    Journal Article
  20. 20

    Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications by Cavazzoni, Patrizia, Mukhopadhyay, Nitai, Carlson, Christopher, Breier, Alan, Buse, John

    Published in British journal of psychiatry (01-04-2004)
    “…In this retrospective analysis, we assessed the short-term risk of treatment-emergent diabetes (TED) among patients with schizophrenia during clinical trials…”
    Get full text
    Journal Article